Victor L. Friedrich

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

38

H-Index

1

About

Victor L. Friedrich has made pioneering contributions to the field of radiation biology, with a particular focus on the development of automated assays for quantifying DNA damage. His most notable work centers on the gamma-H2AX immunocytochemistry assay, a critical tool for measuring ionizing radiation-induced double-strand breaks in cells. Friedrich’s landmark 2009 paper, "Development of an Automated γ-H2AX Immunocytochemistry Assay," which has garnered 38 citations, introduced a significantly automated method for quantifying this emerging biomarker. This innovation has broad applications in assessing physiological responses to radiation exposure, particularly in cancer research. By applying this assay to PC-3 and DU145 prostate cancer cells, Friedrich demonstrated its utility in evaluating radiation-induced damage, thereby advancing both basic radiobiology and clinical radiotherapy. His work has been instrumental in streamlining high-throughput screening for DNA damage, enabling more efficient studies of cellular repair mechanisms and radiation sensitivity. Friedrich’s contributions have not only enhanced our understanding of double-strand break dynamics but also provided a practical tool for researchers and clinicians aiming to optimize radiation treatment protocols.

Research Focus

Key Achievements

1
H-Index
1
Papers
38
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Development of an Automated γ-H2AX Immunocytochemistry Assay
38 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago